Conditions: Macular Edema Diabetes Mellitus
Allocation: RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 40
Healthy volunteers: no

Brief summary:
There is a need to find an effective therapy for diabetic patients who develop macular edema after cataract surgery.

Detailed description:
The objective of this study is to assess the safety and efficacy of the OZURDEX® intraocular implant in patients with diabetes mellitus, who develop macular edema after cataract surgery

Arms:
arm 1: OZURDEX (dexamethasone posterior segment drug delivery system (DEX PS DDS), 0.7 mg arm 2: NSAID eye drop: Acular LS Steriod eye drop: Pred Forte

Interventions: intervention 1: Dexamethasone intravitreal implant intervention 2: Steroid plus NSAID eye drop combination therapy
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: